Molecular and therapeutic frontiers in anemia therapy

Rai, Nilesh, Abdel-Wahab, Omar, Zhang, Lingbo (May 2026) Molecular and therapeutic frontiers in anemia therapy. Journal of Clinical Investigation, 136 (10). ISSN 1558-8238

PDF 10.1172.JCI203401.pdf - Published Version Available under License Creative Commons Attribution. Download (2MB)

Abstract

Anemia affects one-third of the population globally and is marked by impaired erythropoiesis that results in substantial mortality and morbidity. Over the past few decades, our understanding of the molecular mechanisms underlying anemia has progressed but translating that knowledge into effective targeted therapeutics remains challenging. Preclinical and clinical studies substantiate the efficacy of modulating erythropoietin-driven signaling pathways to stimulate erythropoiesis. Additional approaches include strategies to maintain iron homeostasis and control iron metabolism, using small molecules and oral supplements. New frontiers in molecular regulation of anemia include perturbation of regulatory genes and spliceosome proteins in erythroid cells, as well as mutation-specific therapeutic approaches. Finally, new evidence supporting the importance of neuronal signaling and mitochondrial dynamics in shaping erythropoiesis is pointing toward novel interventions. Here, we discuss the molecular and genetic factors underlying defective erythropoiesis and highlight current and emerging therapies, including molecular targets to overcome drug resistance.

Item Type:	Paper
Subjects:	diseases & disorders diseases & disorders > anemia diseases & disorders > bone diseses
CSHL Authors:	Zhang, Lingbo Rai, Nilesh
Communities:	CSHL labs > Zhang L. lab CSHL Post Doctoral Fellows
SWORD Depositor:	CSHL Elements
Depositing User:	CSHL Elements
Date:	15 May 2026
Date Deposited:	22 May 2026 12:13
Last Modified:	22 May 2026 12:13
PMCID:	PMC13178661
URI:	https://repository.cshl.edu/id/eprint/42206

Actions (login required)

Administrator's edit/view item